Search Results

1 - 10 of 206 items :

Clear All
VEGF expression in pancreatic cancer and other malignancies: a review of the literature

REFERENCES 1. HOEBEN A., LANDUYT B., HIGHLEY M.S., WILDIERS H., VAN OOSTEROM A.T., DE BRUIJN E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004; 56 (4):549-580. 2. CRIVELLATO E. The role of angiogenic growth factors in organogenesis. Int J Dev Biol. 2011; 55 (4-5):365-75. 3. GERHARDT H.. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis. 2008; 4: 241-246. 4. TAKAHASHI H., SHIBUYA M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and

Open access
The Impact of Hyperglycemia on VEGF Secretion in Retinal Endothelial Cells

. Curr Neuropharmacol 2016 Aug 13. [Epub ahead of print] 5. Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-80. 6. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and micro-angiopathy in an adult primate. Ophthalmology 1996;103:1820-8. 7. Vidro EK, Gee S, Unda R, et al. Glucose and TGF β2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr Eye Res 2008

Open access
Antiapoptotic Proteins MCL-1 and BCL-2 as Well as Growth Factors FGF And VEGF Influence Survival of Peripheral Blood and Bone Marrow Chronic Lymphocytic Leukemia Cells

-Cappio F.(2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 114:3367-75. DOI: 10.1182/blood-2009-06-225326 7. Maffei R, Martinelli S, Castelli I, Santachiara R, Zucchini P, et al (2010) Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. Leuk Res 34: 312-321. DOI: 10.1016/j.leukres.2009.06.023 8. Farahani M, Treweeke AT, Toh CH, Till KJ, Harris RJ, et al (2005) Autocrine VEGF mediates the antiapoptotic effect of CD154 on

Open access
Survivin and Vegf as Novel Biomarkers in Diagnosis of Endometriosis/ Survivin i vegf kao novi biomarkeri u dijagnostici endometrioze

women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 2003; 3: 81-9. 18. Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.Arch Gynecol Obstet 2013; 288(4): 859-65. 19. Dai H, Zhao S, Xu L, Chen A, Dai S. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue. Oncol Rep 2010; 23

Open access
Potential Pro-Inflammatory Role Of VEGF In Patients With Crohn’s Disease

ABBREVIATIONS ABC -Avidin-Bioton peroxidase Complex CD -Crohn’s disease CDK -Cyclin dependent kinase CARD -Caspase activating recruitment domain DNA - Deoxyribonucleic acid ELISA -Enzyme Linked Immunosorbent Assay IBD -Inflammatory bowel disease (IBD) IFN-γ - Interferon-γ IL -Interleukins MAPK -Mitogen Activated Protein Kinase NF-kB –Nuclear factor kappa light chain enhancer of activated B cells NOD2 -Nucleotide binding oligomerization domain containing protein 2 NK cells -Natural Killer Cells VEGF - Vascular endothelial growth

Open access
Influence Of The Number Of Platelets And Hemoglobin Concentrations In Predicting The Development Of Proteinuria Induced By The Administration Of Bevacizumab

REFERENCES 1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disesase. Nature Medicine 1995;1:27-31. 2. Jain RK, “Molecular Regulation of Vessel Maturation,” Nature Medicine 2003; 9:685-693. 3. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Department of Molecular Oncology. 2000; 55:15-35. 4. Dunst, J., Pigorsch, S., Hansgen, G., Hintner, I., Lautenschlager, C., Becker, A. Low hemoglobin is associated with increased levels of vascular endothelial growth factor (VEGF) in cancer patients

Open access
Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy

may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-5. DOI: 10.1038/359843a0 6. Zhang X, Bao S, Hambly BD, Gillies MC. Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy. Int J Biochem Cell Biol. 2009;41(12):2368-71. DOI: 10.1016/j.biocel.2009.07.011 7. Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organogenesis. 2010;6(2):107-14.DOI: 10.4161/org.6.2.11687 8. Ropper AH, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, et al. Vascular

Open access
Adrenomedullin administration alters vascular endothelial growth factor levels in rats in cold stress

, Browder T, O’Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 1997; 390: 404-7. 6. Ribatti D, Conconi MT, Nussdorfer GG. Nonclassic endogenous regulators of angiogenesis. Pharmacol Rev. 2007; 59:185-205. 7. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth actor (VEGF) and its receptors. FASEB J. 1999; 13:9-22. 8. Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH. Up-regulation of hypoxia-inducible factors HIF-1 alpha and HIF-2alpha

Open access
Role of vascular endothelial growth factor receptor in the pro-proliferation activity of CD40-CD40L in AGS gastric cancer cells

:337-41. 8. Qi CJ, Zheng L, Ma HB, Fei M, Qian KQ, Shen BR, Wu CP, Vihinen M, Zhang XG. A novel mutation in CD40 and its functional characterization. Hum Mutat. 2009; 30:985-94. 9. Murugaiyan G, Martin S, Saha B. CD40-induced countercurrent conduits for tumor escape or elimination? Trends Immunol. 2007; 28:467-73. 10. Farahani M, Treweeke AT, Toh CH, Till KJ, Harris RJ, Cawley JC, Zuzel M, Chen H. Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells. Leukemia. 2005; 19:524-30. 11. Sabel MS, Yamada M

Open access
The Prognostic Role of Vascular Endothelial Growth Factor-A Expression in Thyroid Carcinomas

: 1000-17. 4. Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998; 94: 715-25. 5. Fenton C, Patel A, Dinauer C, et al. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid 2000; 10: 349-57. 6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64. 7. Lin JD, Chao TC

Open access